Literature DB >> 18698132

Osteoblast differentiation stage-specific expression of the pyrophosphate-generating enzyme PC-1.

Nan E Hatch1, Renny T Franceschi.   

Abstract

Fibroblast growth factor (FGF) signaling plays a critical role in skeletal development, yet the mechanism by which FGFs affect bone mineralization is not well understood. Review of the literature investigating effects of FGF signaling on bone mineralization indicates that FGFs may stimulate expression of factors that prevent mineralization in the short term and enhance mineralization in the long term. Pyrophosphate is an ideal example of a factor that, dependent upon environment, has the capacity to inhibit or enhance mineralization. PC-1 is the primary generator of pyrophosphate in osteoblastic cells; therefore, regulated expression of PC-1 by FGFs may be a principal mechanism by which FGF signaling affects bone mineralization. We previously showed that FGF2 induces PC-1 expression in preosteoblastic cells and that this induction is differentiation stage dependent. In order to more directly investigate the mechanism by which PC-1 expression is regulated, we have cloned a 2.8-kb region of the PC-1 gene promoter and constructed a PC-1 gene promoter/firefly luciferase reporter construct. Results indicate that this construct is specifically responsive to FGF2 or ascorbate (an inducer of osteoblast differentiation). Promoter responsiveness to FGF2 is significantly diminished upon osteoblast differentiation, and increases in promoter activity that occur with osteoblast differentiation are inhibited by FGF2 treatment. These results indicate that the mechanism of PC-1 induction by FGF2 in preosteoblastic cells is distinct from the mechanism of induction that occurs with osteoblast differentiation. These results also indicate that PC-1 may play multiple and distinct roles in the development of mineralized tissues. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18698132      PMCID: PMC3709482          DOI: 10.1159/000151375

Source DB:  PubMed          Journal:  Cells Tissues Organs        ISSN: 1422-6405            Impact factor:   2.481


  15 in total

1.  Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation.

Authors:  A Montero; Y Okada; M Tomita; M Ito; H Tsurukami; T Nakamura; T Doetschman; J D Coffin; M M Hurley
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

2.  Matrix vesicle plasma cell membrane glycoprotein-1 regulates mineralization by murine osteoblastic MC3T3 cells.

Authors:  K Johnson; A Moffa; Y Chen; K Pritzker; J Goding; R Terkeltaub
Journal:  J Bone Miner Res       Date:  1999-06       Impact factor: 6.741

3.  Systemic administration of acidic fibroblast growth factor (FGF-1) prevents bone loss and increases new bone formation in ovariectomized rats.

Authors:  C R Dunstan; R Boyce; B F Boyce; I R Garrett; E Izbicka; W H Burgess; G R Mundy
Journal:  J Bone Miner Res       Date:  1999-06       Impact factor: 6.741

4.  Sustained osteomalacia of long bones despite major improvement in other hypophosphatasia-related mineral deficits in tissue nonspecific alkaline phosphatase/nucleotide pyrophosphatase phosphodiesterase 1 double-deficient mice.

Authors:  H Clarke Anderson; Dympna Harmey; Nancy P Camacho; Rama Garimella; Joseph B Sipe; Sarah Tague; Xiaohong Bi; Kristen Johnson; Robert Terkeltaub; José Luis Millán
Journal:  Am J Pathol       Date:  2005-06       Impact factor: 4.307

5.  Effect of pyrophosphate and two diphosphonates on 45Ca and 32Pi uptake and mineralization by matrix vesicle-enriched fractions and by hydroxyapatite.

Authors:  T C Register; R E Wuthier
Journal:  Bone       Date:  1985       Impact factor: 4.398

6.  The nucleoside triphosphate pyrophosphohydrolase isozyme PC-1 directly promotes cartilage calcification through chondrocyte apoptosis and increased calcium precipitation by mineralizing vesicles.

Authors:  K Johnson; K Pritzker; J Goding; R Terkeltaub
Journal:  J Rheumatol       Date:  2001-12       Impact factor: 4.666

7.  FGF2 alters expression of the pyrophosphate/phosphate regulating proteins, PC-1, ANK and TNAP, in the calvarial osteoblastic cell line, MC3T3E1(C4).

Authors:  Nan E Hatch; Francisco Nociti; Erica Swanson; Mark Bothwell; Martha Somerman
Journal:  Connect Tissue Res       Date:  2005       Impact factor: 3.417

8.  Linked deficiencies in extracellular PP(i) and osteopontin mediate pathologic calcification associated with defective PC-1 and ANK expression.

Authors:  Kristen Johnson; James Goding; Deborah Van Etten; Adnan Sali; Shou-Ih Hu; David Farley; Hollis Krug; Lovisa Hessle; José Luis Millán; Robert Terkeltaub
Journal:  J Bone Miner Res       Date:  2003-06       Impact factor: 6.741

9.  Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization.

Authors:  Lovisa Hessle; Kristen A Johnson; H Clarke Anderson; Sonoko Narisawa; Adnan Sali; James W Goding; Robert Terkeltaub; José Luis Millan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-24       Impact factor: 11.205

10.  Causal link between nucleotide pyrophosphohydrolase overactivity and increased intracellular inorganic pyrophosphate generation demonstrated by transfection of cultured fibroblasts and osteoblasts with plasma cell membrane glycoprotein-1. Relevance to calcium pyrophosphate dihydrate deposition disease.

Authors:  R Terkeltaub; M Rosenbach; F Fong; J Goding
Journal:  Arthritis Rheum       Date:  1994-06
View more
  1 in total

1.  FGF and ERK signaling coordinately regulate mineralization-related genes and play essential roles in osteocyte differentiation.

Authors:  Ai Kyono; Nanthawan Avishai; Zhufeng Ouyang; Gary E Landreth; Shunichi Murakami
Journal:  J Bone Miner Metab       Date:  2011-06-17       Impact factor: 2.626

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.